相关实验视频

Updated: May 10, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

使用伪型系统探索SARS-CoV-2变种的免疫逃避

Haixiao Duan¹, Ershuai Zhang¹, Ge Ren¹

¹National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, College of Bioengineering, Hubei University of Technology, Wuhan, China.

|May 3, 2024

概括

一个新的伪病毒系统有效地模拟了像XBB.1.5这样的SARS-CoV-2变种,揭示了它们增强的免疫逃避. 这个工具有助于预测疫苗对新出现的COVID-19菌株的有效性.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

自2022年底以来,美国的2019年冠状病毒病 (COVID-19) 病例主要由SARS-CoV-2 XBB.1.5变种主导.
了解循环SARS-CoV-2变种的免疫逃避特性对于公共卫生至关重要.

研究的目的:

开发和验证一种伪病毒 (PsV) 系统,用于在生物安全级别2 (BSL-2) 实验室研究SARS-CoV-2变种感染.
通过中和试验,评估各种SARS-CoV-2PsV变体的免疫逃避能力,包括XBB.1.5.

主要方法:

用ZsGreen1和火 luciferase (Fluc) 双重记者基因设计了一个lentiviral 载体系统,用于PsV生产.
创建了一个SARS-CoV-2PsV变体 (原型,Delta,BA.5,XBB.1,XBB.1.5) 的小组.
一个表达人类ACE2的HEK-293T细胞系被用于感染研究.
使用PF-D-Trimer蛋白疫苗免疫的老鼠血清进行了中和试验.

主要成果:

开发的PsV系统成功模拟了不同的SARS-CoV-2变种.
与原型,Delta和BA.5 PsV变种相比,XBB变种,特别是XBB.1.5,表现出明显更强的免疫逃避.
该研究验证了PsV变体在中和试验中的有用性.

结论:

伪病毒系统为调查SARS-CoV-2变种感染性和免疫反应提供了一个强大的平台.
这些发现突显了XBB.1.5变种的增强免疫逃避,强调了需要更新疫苗或治疗方法的需要.
这种中和测试方法可以预测对未来SARS-CoV-2变种的干预措施的有效性.

关键词:

ACE2-m 桃-293TT 在线购买免疫逃脱是为了逃脱免疫.中和测试试验中和测试试验伪病毒是一种伪病毒.这就是SARS-CoV-2病毒.

更多相关视频

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...